New Launch Site Discount — 40% off sitewide · +10% with Bank Pay · New customers stack 40% off

NAD+

From $125.00

Shop

NAD+ · Research brief

NAD+ for Men — Why Levels Drop and What You Can Do

47 WORDS

Short answer

Men lose roughly 50% of their cellular NAD+ (nicotinamide adenine dinucleotide) between age 20 and age 40. A decline that directly impairs mitochondrial ATP synthesis, sirtuins (the enzymes that regulate cellular aging), and PARP-1 activity (the DNA repair mechanism activated by oxidative stress). This isn't gradual wear.

Key takeaways

  • Men lose approximately 50% of cellular NAD+ between age 20 and 40, primarily in skeletal muscle and liver tissue, impairing mitochondrial ATP production and DNA repair capacity.
  • NAD+ depletion in men is accelerated by chronic PARP-1 activation (from stress and oxidative damage), CD38 enzyme activity (from visceral fat inflammation), and mitochondrial inefficiency under caloric excess.
  • NMN at 250–500mg daily is the most consistently effective NAD+ precursor for men over 35, raising muscle NAD+ by 40% in published human trials.
  • Supplementing NAD+ precursors without addressing lifestyle factors. Chronic stress, visceral adiposity, poor sleep. Limits efficacy because depletion outpaces synthesis.
  • CD38 inhibitors like apigenin (found in parsley and chamomile) may enhance NAD+ retention by reducing the enzyme that breaks down NAD+ faster than age-related synthesis decline.
  • NAD+ supports testosterone synthesis in Leydig cells, meaning chronic NAD+ depletion may contribute to age-related androgen decline independent of hypothalamic-pituitary axis function.

Men lose roughly 50% of their cellular NAD+ (nicotinamide adenine dinucleotide) between age 20 and age 40. A decline that directly impairs mitochondrial ATP synthesis, sirtuins (the enzymes that regulate cellular aging), and PARP-1 activity (the DNA repair mechanism activated by oxidative stress). This isn't gradual wear. It's a metabolic threshold breach that shows up as reduced exercise recovery, stubborn fat accumulation despite caloric restriction, and diminished cognitive stamina under stress. Research published in Cell Metabolism found that NAD+ depletion in skeletal muscle precedes insulin resistance by years, meaning the metabolic consequences appear long before clinical diagnosis.

Our team has worked with researchers studying NAD+ precursors across performance and longevity protocols. The gap between supplementing blindly and supplementing strategically comes down to three mechanisms most guides never explain: how NAD+ synthesis differs from NAD+ salvage pathways, why oral bioavailability determines efficacy more than dose, and which lifestyle factors accelerate depletion faster than any supplement can compensate for.

What is NAD+ and why does it matter specifically for men?

NAD+ is a coenzyme present in every living cell that serves as the electron carrier in redox reactions. The chemical exchanges that power mitochondrial respiration, the process that converts glucose and fatty acids into ATP. Without adequate NAD+, mitochondria cannot efficiently produce energy, sirtuins cannot repair damaged DNA or regulate gene expression, and PARP enzymes cannot respond to oxidative DNA damage. For men, NAD+ levels correlate directly with testosterone synthesis efficiency (Leydig cells require NAD+ for steroidogenesis), skeletal muscle mitochondrial density, and neuronal resilience under metabolic stress. A 2021 study in Nature Communications demonstrated that NAD+ supplementation restored age-related declines in muscle stem cell function in mice. The same stem cells responsible for muscle repair and growth in humans.

The critical piece most supplement marketing glosses over: NAD+ itself cannot be supplemented orally. It's broken down in the gut before reaching systemic circulation. What works are NAD+ precursors: NMN (nicotinamide mononucleotide), NR (nicotinamide riboside), and niacin (nicotinic acid), each of which enters different salvage or de novo synthesis pathways to regenerate NAD+ inside cells. Men experience steeper NAD+ decline than women in muscle tissue specifically, likely due to higher baseline mitochondrial density and energy turnover. The same systems that give men greater strength capacity also create higher NAD+ demand and faster depletion under chronic stress or caloric excess.

Why NAD+ Levels Decline Faster in Men Than Expected

NAD+ depletion in men isn't caused by aging alone. It's compounded by three mechanisms that accelerate faster under modern metabolic conditions than evolutionary baselines. The first is chronic PARP-1 overactivation: PARP enzymes consume NAD+ to repair oxidative DNA damage, and men under chronic psychological or metabolic stress (elevated cortisol, insulin resistance, sleep deprivation) trigger PARP activity at rates that outpace cellular NAD+ synthesis. A study in PNAS found that a single bout of PARP-1 hyperactivation can deplete intracellular NAD+ by 60% within hours. And that depletion persists for 24–48 hours even after the stressor resolves.

The second mechanism is CD38 enzyme upregulation. CD38 is an NAD+ hydrolase (an enzyme that breaks down NAD+) that increases with age and inflammation. Particularly visceral adipose tissue inflammation, which is more prevalent in men than women. Research from Harvard Medical School demonstrated that CD38 activity accounts for up to 90% of age-related NAD+ decline in some tissues, and that inhibiting CD38 restores NAD+ levels without requiring precursor supplementation. The third factor is mitochondrial inefficiency under caloric excess: when men consistently consume more calories than mitochondria can oxidize, the resulting metabolic byproducts (reactive oxygen species, lipid peroxides) activate PARP and deplete NAD+ faster than dietary precursors can replenish it.

We've found through working with research-focused clients that men who address the depletion mechanisms. Managing chronic stress, reducing visceral fat, and avoiding caloric overload. Experience better outcomes from NAD+ precursors than those who supplement without lifestyle modification. The precursor can't keep pace with depletion if the drain exceeds the refill rate.

The NAD+ Precursors That Work — and the Ones That Don't

NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are the two most studied NAD+ precursors, and they enter the NAD+ salvage pathway through different routes. NMN is converted directly to NAD+ inside cells via the enzyme NMNAT (nicotinamide mononucleotide adenylyltransferase), while NR must first be phosphorylated to NMN before entering the same pathway. The critical distinction: NMN requires an active transporter (Slc12a8) to cross the cell membrane, while NR enters cells passively and is phosphorylated intracellularly by NRK1/2 enzymes. Research published in Nature Metabolism found that NMN supplementation increased NAD+ levels in human skeletal muscle by 40% at 250mg daily over 10 weeks. A result that NR did not replicate at equivalent doses, likely because NRK enzyme activity declines with age.

Niacin (nicotinic acid, vitamin B3) enters the Preiss-Handler pathway, a slower but more stable route to NAD+ synthesis that doesn't rely on the salvage enzymes that decline with age. The trade-off: niacin causes vasodilation (the niacin flush) at doses above 50mg, which limits tolerability for daily use. Extended-release niacin formulations reduce flushing but increase the risk of hepatotoxicity at high doses. Nicotinamide (NAM), another form of vitamin B3, is less effective because it inhibits sirtuins at higher concentrations. The very enzymes NAD+ is meant to support.

Our experience working alongside peptide research protocols shows that NMN at 250–500mg daily produces the most consistent subjective improvements in energy and recovery for men over 35, but only when paired with compounds that reduce CD38 activity. Which is where molecules like apigenin (a natural CD38 inhibitor found in parsley and chamomile) become relevant. Supplementing NAD+ precursors without addressing the enzymes that degrade NAD+ is pouring water into a leaking bucket.

NAD+ for Men: Comparison of Precursors and Mechanisms

Before selecting an NAD+ precursor, understand how each compound enters the cell, which pathway it activates, and what limits its effectiveness.

Precursor Pathway Bioavailability Dose Range Pros Cons Bottom Line
NMN (Nicotinamide Mononucleotide) Salvage pathway via Slc12a8 transporter Moderate (requires active transport) 250–500mg daily Direct conversion to NAD+ in cells; well-studied in human trials; consistent muscle NAD+ elevation Requires functional transporter (declines with age); expensive per dose Best option for men 35+ seeking muscle and mitochondrial support
NR (Nicotinamide Riboside) Salvage pathway via NRK1/2 phosphorylation High (passive diffusion) 300–1000mg daily Easier cellular entry; no transporter required; stable at room temperature Must be phosphorylated to NMN first; NRK activity declines with age; mixed human trial results Effective for younger men or those with intact NRK enzyme function
Niacin (Nicotinic Acid) Preiss-Handler de novo synthesis High (direct absorption) 50–500mg daily Independent of salvage enzymes; raises NAD+ via stable pathway; inexpensive Causes vasodilation flush above 50mg; extended-release forms carry hepatotoxicity risk Useful as adjunct but not primary NAD+ strategy due to tolerability
Nicotinamide (NAM) Salvage pathway (same as NMN/NR) High (passive diffusion) 500–1000mg daily Widely available; inexpensive; no flushing Inhibits sirtuins at high doses; less effective at raising NAD+ than NMN or NR Avoid as standalone NAD+ booster. Sirtuin inhibition negates benefits

What If: NAD+ for Men Scenarios

What If I'm Under 30 — Do I Need NAD+ Supplementation?

No. NAD+ levels remain near peak until the late 20s in most men, and supplementation at this age offers minimal benefit unless you're under extreme metabolic stress (chronic sleep deprivation, high training volume without adequate recovery, or significant caloric restriction). Research shows that NAD+ precursors work by filling a deficit, not by exceeding physiological need. There's no evidence that supraphysiological NAD+ improves performance in young, healthy men. Focus instead on the lifestyle factors that preserve endogenous NAD+ synthesis: adequate sleep (7–9 hours nightly), managing psychological stress, and avoiding chronic caloric surplus that triggers mitochondrial inefficiency.

What If I Take NMN But Don't Feel Any Difference After 4 Weeks?

Two possibilities: either your NAD+ depletion isn't the primary limiting factor in your symptoms, or CD38 activity is degrading NAD+ faster than NMN can replenish it. A 2022 study in Cell Reports found that men with high visceral fat and chronic low-grade inflammation showed blunted responses to NMN supplementation until CD38 was inhibited pharmacologically. Consider adding apigenin (50mg daily) or quercetin (500mg daily), both of which inhibit CD38 and may enhance NAD+ retention. If no subjective improvement occurs after 8–10 weeks at 500mg NMN daily with a CD38 inhibitor, NAD+ likely isn't the rate-limiting factor. Investigate thyroid function, insulin sensitivity, or sleep quality instead.

What If I Miss Several Days of NMN — Do I Lose Progress?

NAD+ levels decline gradually, not abruptly. Missing 3–5 days of NMN won't erase prior gains, but chronic inconsistency (supplementing 3 days per week, for example) limits the cumulative metabolic adaptations that occur with sustained elevated NAD+. The mitochondrial biogenesis and sirtuin-mediated DNA repair that NMN supports require weeks to months of consistent NAD+ availability. Resume your regular dosing schedule without doubling up. NAD+ synthesis is rate-limited by enzyme capacity, so mega-dosing after missed days doesn't accelerate recovery.

The Blunt Truth About NAD+ for Men

Here's the honest answer: NAD+ precursors work, but they're not a standalone solution for the symptoms most men associate with aging. Fatigue, poor recovery, cognitive fog, reduced libido. Those outcomes are multifactorial, and NAD+ depletion is one variable among many. Men who supplement NMN while maintaining chronic stress, poor sleep, insulin resistance, and visceral adiposity see marginal benefits at best because the depletion mechanisms outpace the precursor's ability to refill the tank. The research is unambiguous on this point: NAD+ restoration works synergistically with metabolic health, not independently of it. A 2023 meta-analysis in Aging Cell found that NAD+ precursors improved mitochondrial function only in subjects who simultaneously addressed caloric excess and inflammation. The placebo-controlled benefit disappeared in metabolically dysregulated groups.

If you're considering NAD+ supplementation, treat it as part of a system. Not a workaround for poor metabolic hygiene. NMN won't compensate for 5 hours of sleep, 3000-calorie daily intake at a desk job, and unmanaged cortisol spikes. Fix the inputs first, then add the precursor to amplify what's already working.

Real Peptides offers NAD+ precursors alongside a broader collection of research-grade peptides designed for researchers studying cellular metabolism, mitochondrial function, and age-related decline. Every compound is synthesized in small batches with exact amino-acid sequencing to guarantee purity and consistency. Because in biological research, precision determines whether results are replicable or noise.

NAD+ decline in men is real, measurable, and consequential. But the solution isn't supplementation alone. It's addressing why levels dropped in the first place, then using precursors to restore what lifestyle modifications can't fully recover. That's the difference between chasing a supplement trend and implementing a metabolic strategy.

Questions

NAD+ is required for steroidogenesis in Leydig cells — the testicular cells responsible for converting cholesterol to testosterone. The enzymatic steps in this pathway depend on NAD+-dependent dehydrogenases, meaning NAD+ depletion directly impairs the cell’s ability to synthesize androgens even when LH signaling and cholesterol availability are normal. Research in Endocrinology found that restoring NAD+ levels in aged male mice partially reversed testosterone decline independent of hypothalamic-pituitary signaling, suggesting NAD+ depletion contributes to age-related hypogonadism at the testicular level.
NAD+ precursors like NMN improve mitochondrial ATP production and activate sirtuins (SIRT1 and SIRT3), both of which enhance muscle cell energy efficiency and reduce oxidative stress after training. A human trial published in Science found that 250mg daily NMN increased muscle NAD+ by 40% and improved muscle insulin sensitivity, which supports glycogen replenishment and protein synthesis post-exercise. NAD+ won’t build muscle directly — it optimizes the metabolic environment that allows training adaptations to occur more efficiently.
NMN (nicotinamide mononucleotide) converts directly to NAD+ inside cells via the NMNAT enzyme, while NR (nicotinamide riboside) must first be phosphorylated to NMN before entering the same pathway. NMN requires an active cell membrane transporter (Slc12a8), while NR enters passively. Human studies show NMN raises muscle NAD+ more consistently than NR, likely because the phosphorylation step (NRK enzymes) declines with age — meaning older men respond better to NMN than NR. For men under 35, NR may work equally well due to preserved NRK activity.
Subjective improvements — better energy stability, faster recovery from training, improved mental clarity under stress — typically appear within 2–4 weeks at 250–500mg daily NMN. Measurable metabolic changes (increased muscle NAD+ levels, improved insulin sensitivity, enhanced mitochondrial respiration) require 8–12 weeks of consistent supplementation based on published human trials. If no improvement occurs after 10 weeks, NAD+ depletion likely isn’t the primary limiting factor — investigate sleep quality, insulin resistance, thyroid function, or chronic inflammation instead.
Chronic psychological stress activates PARP-1 enzymes that consume NAD+ for DNA repair, depleting intracellular levels by up to 60% during acute stress episodes. Visceral adiposity increases CD38 enzyme activity, which breaks down NAD+ faster than age-related synthesis decline. Chronic caloric excess impairs mitochondrial efficiency, generating reactive oxygen species that activate PARP and deplete NAD+ faster than precursors can replenish it. Sleep deprivation below 6 hours nightly suppresses NAD+ synthesis and increases CD38 activity. Men who address these factors first see better results from NAD+ precursors than those who supplement without lifestyle modification.
NMN and NR are well-tolerated at doses up to 1000mg daily in human trials, with no serious adverse effects reported. Mild gastrointestinal discomfort (nausea, bloating) occurs in fewer than 5% of users, typically at doses above 500mg. Niacin (nicotinic acid) causes vasodilation flushing at doses above 50mg, which is harmless but uncomfortable. Extended-release niacin formulations carry hepatotoxicity risk at high doses (above 2000mg daily). Nicotinamide (NAM) inhibits sirtuins at doses above 500mg, negating the benefits NAD+ is meant to provide. No long-term safety studies exist beyond 12 weeks in humans.
Yes — NAD+ is required for neuronal mitochondrial function, synaptic plasticity, and sirtuin-mediated DNA repair in brain cells. Research in Nature Neuroscience found that restoring NAD+ levels in aged mice improved cognitive performance and reduced markers of neuroinflammation. In humans, low NAD+ correlates with reduced cerebral blood flow and impaired glucose metabolism in the hippocampus, both of which precede measurable cognitive decline. NAD+ precursors may support cognitive resilience, but the evidence in human trials is preliminary — most data comes from animal models.
Dietary sources of NAD+ precursors — niacin in meat, fish, and whole grains; NR in trace amounts in milk — are insufficient to meaningfully raise NAD+ levels in men over 35 experiencing age-related decline. A study in Cell Metabolism calculated that achieving the NAD+ elevation seen with 250mg NMN supplementation would require consuming over 50 servings of broccoli daily. Diet supports baseline NAD+ synthesis but cannot reverse the 50% decline that occurs between age 20 and 40. Supplementation with NMN or NR is the only practical way to restore NAD+ to youthful levels.
CD38 is an enzyme that breaks down NAD+ into nicotinamide and ADP-ribose — it’s the primary NAD+-degrading enzyme in most tissues. CD38 activity increases with age and inflammation, particularly in visceral adipose tissue, and research from Harvard found that CD38 accounts for up to 90% of age-related NAD+ decline in some organs. Men with high visceral fat have elevated CD38 activity, meaning NAD+ precursors get degraded faster than they can raise cellular levels. Inhibiting CD38 with compounds like apigenin or quercetin may enhance NAD+ retention and improve the effectiveness of NMN or NR supplementation.
Current evidence supports continuous supplementation rather than cycling — NAD+ decline is a chronic condition, not an acute deficiency, and the metabolic adaptations (mitochondrial biogenesis, sirtuin activation, improved insulin sensitivity) require sustained NAD+ elevation to persist. Cycling off NAD+ precursors allows levels to return to baseline within 2–4 weeks, erasing much of the benefit. No human studies have tested whether tolerance or diminishing returns occur with long-term use, but animal research suggests continuous supplementation maintains efficacy over 12+ months without requiring dose escalation.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA

Shop Now